CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
MorphoSys AG - ADR Company Snapshot
MorphoSys AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MorphoSys AG with three other companies in this sector in UNITED STATES : argenx SE (2019 sales of $78.00 million ), Adaptive Biotechnologies Corp ($85.07 million of which 100% was Biotechnology & Medical Research), and Luna Innovations Incorporated ($70.52 million of which 63% was Products and licensing).

Sales Analysis. During the year ended December of 2019, sales at MorphoSys AG were $80.20 million. This is a decrease of 11.0% versus 2018, when the company's sales were $90.07 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, MorphoSys AG had sales of $84.48 million. Contributing to the drop in overall sales was the 39.3% decline in Proprietary Development, from $63.17 million to $38.32 million. . However, these declines were partially offset by the increase in sales of Partnered Discovery (up 55.7% to $41.88 million) .
   
   
 
  Stock Performance Chart for MorphoSys AG - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 25.57
(Figures in U.S. Dollars)
1 Week 22.9%   13 Weeks -4.2%  
4 Weeks -29.4%   52 Weeks 12.5%  
 
MorphoSys AG - ADR Key Data:
  Ticker: MOR Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 80,204,490
(Year Ending Jan 2020).
Employees: 426
  Currency: U.S. Dollars Market Cap: 3,245,565,120
  Fiscal Yr Ends: December Shares Outstanding: 126,928,632
  Share Type: American Depository Recei Closely Held Shares: 5,770,836
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.